ZS three-lens brief
Evidence-based stock research on ZS. Three independent lenses — Quality, Momentum, Context — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Underperforming SPY by 17.8pp over 30 days. · Trading at 9% of its 52-week range — deep in the lower band.
- Trading at 9% of its 52-week range — deep in the lower band.
- Underperforming SPY by 17.8pp over 30 days.
- Currently unprofitable on a trailing basis — no P/E multiple available.
- Analyst mean target $229.45 — 69% above current (45 analysts).
- Debt-to-equity of 85.0 — balance-sheet-heavy.
ZS closed at $135.50 (+1.90%) as of 2026-04-25. Market cap: $21.79B. Positives: analyst mean target $229.45 — 69% above current (45 analysts).. Concerns: trading at 9% of its 52-week range — deep in the lower band.; underperforming SPY by 17.8pp over 30 days.. Last quarter: Revenue $815.75M, net income -$34.31M, free cash flow $1.02B.
Why three lenses on ZS, not one.
A single reasoning model has blind spots it doesn’t know about. We examine ZSacross Quality (fundamentals), Momentum (price action and sentiment), and Context (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/ZS" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath ZS brief"></iframe>